Correction to: Equivalence trial of proposed denosumab biosimilar GP2411 and reference denosumab in postmenopausal osteoporosis: the ROSALIA study. . J Bone Miner Res 2024 May 22:zjae077. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Correction to: Equivalence trial of proposed denosumab biosimilar GP2411 and reference denosumab in postmenopausal osteoporosis: the ROSALIA study. J Bone Miner Res 2024 May 22:zjae077. doi: 10.1093.
PMID: 38775660